Kenneth Longo

Kenneth Longo began their work experience as a Postdoctoral Fellow at the University of Michigan Medical School in 1998, where they developed and phenotyped transgenic mice. Kenneth then moved on to positions at Elixir Pharmaceuticals, Dicerna Pharmaceuticals, Proteostasis Therapeutics, and ultimately, Wave Life Sciences, where they held various roles in data science and bioinformatics, eventually becoming Vice President of Discovery Data Science in 2021.

Kenneth Longo completed their Bachelor of Science degree in Biology at the University of New Hampshire from 1988 to 1993. Kenneth then went on to earn their Ph.D. in Physiology at the Geisel School of Medicine at Dartmouth from 1993 to 1998.